THE IMPORTANCE OF POSTMARKETING DRUG SURVEILLANCE

被引：0

|

作者：

SMART, AJ

WALTERS, L

机构：

来源：

SOUTH AFRICAN MEDICAL JOURNAL | 1992年 / 82卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：383 / 384

页数：2

相关论文

共 50 条

[21] POSTMARKETING DRUG SURVEILLANCE BY RECORD LINKAGE IN TAYSIDE
CROMBIE, IK
BROWN, SV
HAMLEY, JG
[J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1984, 38 (03) : 226 - 231
[22] POSTMARKETING SURVEILLANCE OF ADVERSE DRUG-REACTIONS
CASTLE, WM
LEWIS, JA
[J]. BRITISH MEDICAL JOURNAL, 1984, 288 (6428): : 1458 - 1459
[23] POSTMARKETING DRUG SURVEILLANCE - ARE OUR PRIORITIES RIGHT
FRIES, JF
[J]. JOURNAL OF RHEUMATOLOGY, 1988, 15 (03) : 389 - 390
[24] POSTMARKETING SURVEILLANCE OF ADVERSE DRUG-REACTIONS
RAWLINS, MD
[J]. BRITISH MEDICAL JOURNAL, 1984, 288 (6433): : 1834 - 1834
[25] An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Misu T.
Kortepeter C.M.
Muñoz M.A.
Wu E.
Dal Pan G.J.
[J]. Drugs - Real World Outcomes, 2018, 5 (2) : 91 - 99
[26] POSTMARKETING SURVEILLANCE - CURRICULUM FOR THE CLINICAL PHARMACOLOGIST .1. POSTMARKETING SURVEILLANCE WITHIN THE CONTINUUM OF THE DRUG APPROVAL PROCESS
JOHNSON, J
TANNER, LA
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (10): : 904 - 911
[27] US FDA enhancing postmarketing drug safety surveillance
[J]. Reactions Weekly, 2019, 1780 (1) : 3 - 3
[28] POSTMARKETING SURVEILLANCE - ACCURACY OF PATIENT DRUG ATTRIBUTION JUDGMENTS
FISHER, S
BRYANT, SG
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (01) : 102 - 107
[29] The ethical issues of the postmarketing surveillance of drug teratogenicity in Hungary
Czeizel, AE
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (07) : 635 - 639
[30] Therapeutic Drug Monitoring Databases for Postmarketing Surveillance of Drug-Drug Interactions
Marianne Gex-Fabry
Luc P. Balant
Androniki E. Balant-Gorgia
[J]. Drug Safety, 2001, 24 : 947 - 959

← 1 2 3 4 5 →